Bibliografia

1. Kasper LH, Shoemaker J. Multiple sclerosis immunology. The healthy immune system vs the MS immune system. Neurology 2010; 74(Suppl 1): S2–S8.
2. Wekerle H, Hohlfeld R. Molecular mimicry in multiple sclerosis. N Engl J Med 2003; 349 (2): 185-6.
3. Ascherio A. Environmental factors in multiple sclerosis. Expert Rev Neurother 2013; 13(12 Suppl): 3-9.
4. Popescu BFG, Pirko I, Lucchinetti CF. Pathology of multiple sclerosis: where do we stand? Continuum (Minneap Minn) 2013; 19(4): 901-21.
5. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-85.
6. Katz Sand IB, Lublin FD. Diagnosis and differential diagnosis of multiple sclerosis. Continuum (Minneap Minn) 2013; 19(4): 922-43.
7. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald Criteria. Ann Neurol 2011; 69: 292-302.
8. Filippi M. Predictive value of MRI findings in multiple sclerosis. Lancet Neurology 2002; 1: 9.
9. Pucci E, Brañas Tato P, D’Amico R, et al. Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst Rev 2007; (1): CD002818.
10. Lublin FD, Reingold SC, Cohen JA, et al. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology 2014; 83(3): 278-86.
11. Tremlett H, Zhao Y, Rieckmann P, Hutchinson M. New perspectives in the natural history of multiple sclerosis. Neurology 2010; 74: 2004-15.
12. Amato MP, Portaccio E. Truly benign multiple sclerosis is rare: let's stop fooling ourselves –Yes. Mult Scler 2012; 18(1): 13-4.
13. Hawkins S. Truly benign multiple sclerosis is rare: let's stop fooling ourselves – No. Mult Scler 2012; 18(1): 11-2.
14. Pugliatti M, Rosati G, Carton H, et al. The epidemiology of multiple sclerosis in Europe. Europ J Neurology 2006; 13: 700-22.
15. Lugaresi A, di Ioia M, Travaglini D, et al. Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis. Neuropsychiatr Dis Treat 2013; 9: 893-914.
16. Solaro C. Management of symptoms in multiple sclerosis. Milano: EDRA; 2013.
17. National Institute for Health and Care Excellence. National Clinical Guideline Centre (UK). Multiple Sclerosis: Management of Multiple Sclerosis in Primary and Secondary Care. London, 2014.
18. Briken S, Gold SM, Patra S, et al. Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial. Mult Scler 2014; 20(3): 382-90.
19. Feinstein A, Dalgas U. The benefits of exercise in progressive MS: some cautious optimism. Mult Scler 2014; 20(3): 269-70.
20. Pucci E, Giuliani G, Solari A, et al. Natalizumab for relapsing remitting multiple sclerosis. Cochrane Database Syst Rev 2011; (10) :CD007621.
21. White AT, Wilson TE, Davis SL, Petajan JH. Effect of precooling on physical performance in multiple sclerosis. Mult Scler 2000; 6(3): 176-80.
22. Smith RM, Adeney-Steel M, Fulcher G, Longley WA. Symptom change with exercise is a temporary phenomenon for people with multiple sclerosis. Arch Phys Med Rehabil 2006; 87: 723-7.
23. Svenningsson A, Falk E, Celius EG, et al. Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting. PLoS One 2013; 8(3): e58643.
24. Decreto Ministeriale 18/2/82. Norme per la tutela sanitaria dell’attività sportiva agonistica. GU.63; 5 marzo 1982.
25. Legge n. 91 del 13 marzo 1995. Norme per la tutela sanitaria degli sportivi professionisti.
26. AA.VV. COCIS 2009/Protocolli cardiologici per il giudizio di idoneità allo sport. Roma: Casa editriceScientifica Internazionale; 2009.
27. Carletti M (a cura di). Memorix- Idoneità sportiva. Miano: Edi.Ermes; 2001.
28. Latimer Cheung AE, Pilutti LA, Hicks AL, et al. Effect of exercise training on fitness, mobility, fatigue, and health-related quality of life among adults with multiple sclerosis: a systematic review to inform guideline development. Arch Phys Med Rehabil 2013; 94: 1800-28.
29. Crutchfield KE. Managing patients with neurologic disorders who participate in sports activities. Sports Neurology 2014; 20: 1657-66.
30. Pinheiro JP, Serrano S, Pedro L. Esclerose multipla e atividade fisica. Rev Med Desportiva 2012; 3(6): 8-11.
31. Kargafard M, Etemadifar M, Baker P, Mehrabi M, Hayatbakhsh R. Effects of aquatic exercise training on fatigue and health-related quality of life in patients with Multiple Sclerosis. Arch Phys Med Rehabil 2012; 93: 1701-8.
32. Kooshiar H, Moshtagh M, Sardar MA, et al. Aquatic exercise effect on fatigue and quality of life of women with multiple sclerosis: a randomized controlled clinical trial. J Sports Med Phys Fitness 2014 [Epub ahead of print].
33. Kurland LT. Trauma and multiple sclerosis. Ann Neurol 1994; 36(suppl): 33-7.
34. Goodin DS, Ebers GC, Johnson KP, et al. The relationship of MS to physical trauma and psychological stress. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1999; 52: 1737-47.
35. Dalgas U, Ingemann-Hansen T, Stenager E. Physical exercise and MS recommendations. Int MS J 2009; 16(1): 5-11.